Renal Pharmacology Flashcards
Finasteride
An androgen receptor complex antagonist that is mostly used in benign prostatic hyperplasia to decrease the rate of growth
It’s actually a 5 alpha reductase inhibitor
Luteinizing hormone
Released by the pituitary in response to stimulation by GnRH to act on the testes to increase testosterone synthesis
Leuprolide/goserelin
GnRH agonists that have modifications that make them last longer and increase their affinity for synthetic agonists.
Given in intramuscular formulation
Agonists are effective in that after they are administered for 2-4 weeks, they down-regulate the GnRH receptors on the pituitary
However, still releasing LH during this timeframe so an AR-antagonist is administered during this time frame to stop “androgen flare”
Degarelix
GnRH antagonist with six amino acid substitutions which make it an antagonist; does not have androgen flare so do not need to use an AR-antagonist with it
Bicalutamide
Nonsteroidal androgen receptor antagonist that is preferred for use to block androgen flair in association with GnRH agonists
Nilutamide
Nonsteroidal androgen receptor antagonist that has the toxicity of alcohol intolerance and diminished ocular adaptation to darkness.
Slightly less diarrhea seen here with these patients in comparison with bicalutamide
Cyproterone
Steroidal androgen receptor antagonist
Has partial agonist activity at large doses so that it acts as a steroid agonist
Associated with liver toxicity
Sipuleucel-T
Used as an autologous cellular immunotherapy for treatment of asymptomatic/symptomatic metastatic and hormone-refractory prostate cancer
Use it early when you first see signs and symptoms
Cabazitaxel
Binds to and stabilizes tubulin so that the spindle does not depolarize to inhibit tumor cell proliferation
Leads to cell cycle arrest and growth stoppage
Used with prednisone
Docetaxel
Antagonizes microtubule spindle disassembly with toxicity of neutropenia and nephrotoxicity
Can cause an infusion reaction
Bacillus Calmette-Guerin
Attenuated live vaccine which causes a granuloma-like reaction in the bladder wall to damage and kill the cancel cells; also damages bladder wall but not that much
Mitomycin
Intravesicular agent that is not absorbed at all so effective ocally
Thiotepa
Activated by CYP450 to form an alkylator with DNA cross-links to lead to DNA damage
Causes immunosuppression and neurotoxic at high doses
Cisplatin
Chemo contraindicated in patients who have renal disease in combination with bladder cancer
Valrubicin
Synthetic analog of doxorubicin and used only for intravesicular reaction for BCG-resistant bladder cancer
Interleukin-2
Activates lymphocytes and can cause adverse effects like hypertension, arrythmias, peripheral edema, etc.
Only 15-40% effective and works to enhance the body’s anti tumor effects
Toxicities in relation to it activating cytotoxic lymphocytes which can cause other bad toxicities
Sunitinib
Oral inhibitor of ATP to intrinsic tyrosine kinase domain of VEGF-R2
Also inhibits other tyrosine kinases
Reduces proliferation and angiogenesis
Sorafenib
Oral inhibitor of VEGF tyrosine kinases within tumor cells to reduce proliferation and angiogenesis
Bevacuzimab
Humanized monoclonal antibody against VEGF that actually binds to the ligand to prevent it binding to the receptor
Commonly given with interferon alpha in renal cell carcinoma treatment
P13K
Pathway by which temsirolimus and everolimus inhibit through acting on the mTOR enzyme complex
mTORC1
Enzyme complex that temsirolimus and everolimus act on which is made up of mTOR and FKB12
These drugs bind to the FKB12 part of the enzyme complex
Enzyme normally phosphorylates S6 kinase and relieves inhibitory action of 4EBP to overall promote protein synthesis and metabolism
mTORC2
Mechanism of resistance to temsirolimus and everolimus - this enzyme complex can be used instead of mTORC1
Cefepime
Fourth-generation cephalosporin that is the best mechanism by which to treat extremely ill UTI patients
Levofloxacin
Fluoroquinolone that previously was front-line treatment for UTI’s and pyelonephritis
Recently resistance has developed, so utilize Bactrim more commonly instead
Given in IV format for complicated pyelo patients (nausea, vomiting, etc.) but can be given orally as well
Resistance can be overcome with high doses of the drug
Aztreonam
Penicillin analog effective against pyelonephritis
Piperacillin-tazobactam
Tazobactam is a beta-lactamase inhibitor so this drug combination works synergistically with broad spectrum activity against gram positive and gram negative organisms
Imipenem
Very resistant to chromosomal beta-lactamases so a good drug option
Broken down pretty quickly with toxicity of hypersensitivity
Aminoglycoside
Frontline treatment for urinary catheter associated UTI along with a fluoroquinolone or other cephalosporin
MOA of aminoglycoside
Bind at start codon during mRNA translation to inhibit mRNA binding
When mRNA does bind, leads to misreading
Blocks further translation of the transcript or allows for incorporation of incorrect amino acid
Amikacin
Aminoglycoside resistant to lots of enzyme inactivation steps so used pretty widely in hospital setting
Ototoxicity
Most damaging of the amino glycoside toxicities
Usually from progressive damage to vestibular and cochlear sensory cells and is usually irreversible
High-pitched tinnitus is usually the first sign associated with this toxicity
Renal toxicity
Aminoglycosides cause renal impairment in 26% of patients receiving them
May manifest as just decreased GFR or could lead to severe ATN
Most important result of renal toxicity is reduced excretion of the drug which can predispose to ototoxicity